Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC)

NCT04055038 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

164

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Ovarian Neoplasms
Serous Adenocarcinoma
BRCA1 Mutation
BRCA2 Mutation
Chemotherapy

Interventions

DRUG: Platinum-Based Drug
DRUG: Conventional chemotherapy

Sponsor

Blokhin's Russian Cancer Research Center